Yasemin Bakkal Temi

9PUBLICATIONS
43CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersVision science
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 24, 2026
Real-World Outcomes of Second-Line Chemotherapy in Metastatic Urothelial Carcinoma.

|May 27, 2026
Prognostic and Predictive Significance of Body Mass Index in Locally Advanced Gastric Cancer Receiving Neoadjuvant Chemotherapy: A Retrospective Multicenter Cohort Study.

|Mar 28, 2026
EASIX Score as an Independent Prognostic Marker in De Novo Metastatic Pancreatic Cancer.

İlkay Çıtakkul, Yasemin Bakkal Temi, Zehra Aytin

|Mar 14, 2026
The Pretreatment Glucose-to-Lymphocyte Ratio as an Independent Prognostic Biomarker in Ovarian Cancer.

Ece Baydar, Yasemin Bakkal Temi, İlkay Çıtakkul

|Feb 27, 2026
Outcomes of First-Line PARP Inhibitor Therapy in Ovarian Cancer: A Multicenter Retrospective Analysis.

Baris Koksal, Hasan Cagri Yildirim, Deniz Can Guven

|Jan 10, 2026
Real-World Evaluation of the HELPP Score and CALLY Index for Preoperative Prognostic Stratification in Resectable Pancreatic Ductal Adenocarcinoma.

İlkay Çıtakkul, Umut Kefeli, Khatira Shukurova

Pageof 2

Frequent Collaborators

5 joint publications

Devrim Çabuk

4 joint publications

Umut Kefeli

4 joint publications

Ece Baydar

2 joint publications

İlkay Çıtakkul